Omega Fund Management Sells Shares in Kestra Medical Despite Revenue Growth

Kestra Medical Technologies (NASDAQ:KMTS) reported a 63% revenue increase but saw Omega Fund Management sell 351,442 shares during Q1 for $8.28 million. The fund reduced its stake to 12.5% of reportable AUM as KMTS stock declined by 1.5% year-to-date.

By Jonathan Ponciano, The Motley Fool Sat, May 16, 2026 at 1:50 AM GMT+3 4 min read · Yahoo Finance · May 15, 2026, 22:50 UTC

Omega Fund Management Sells Shares in Kestra Medical Despite Revenue Growth

Tickers: $KMTS

Topics: Kestra Medical SEC filing stock ownership

Read the full article at Yahoo Finance

More World news

Nvidia Faces Leadership Transition as Jensen Huang Resigns Amid Investigation Seeking Alpha · November 12, 2026, 18:30 UTC
SOLV Energy Reports Record Q3 2026 Results and Raises Full-Year Guidance Motley Fool · November 12, 2026, 19:09 UTC
Clear Secure Reports Strong Q3 Earnings and Raises Full Year Guidance Amid Expansion into Identity Verification CNBC · November 12, 2026, 19:09 UTC
Nectar Launches AI Agent to Automate Influencer Discovery and Outreach TechCrunch · November 12, 2026, 19:11 UTC
Cohen & Company Appoints Daniel Cohen as CEO with $500 Million Revenue Target Seeking Alpha · November 12, 2026, 19:10 UTC
X-Energy Receives Early NRC Construction Permit and Anticipates Dow Investment Decision by 2027 Seeking Alpha · November 12, 2026, 19:10 UTC
Alvotech Shares Decline Following Third Quarter Earnings Miss Seeking Alpha · November 12, 2026, 19:05 UTC
Saga Communications Projects $5.7 Million in 2026 Political Revenue Amid Q4 Growth Seeking Alpha · November 12, 2026, 19:00 UTC
Corteva Forecasts 2026 Operating EBITDA Between $1.1B and $1.125B Amid Brazilian Market Pressures Seeking Alpha · November 12, 2026, 19:00 UTC
DPC Holdings PLC Reports Record Q3 Revenue Growth and Issues 2027 Financial Guidance Seeking Alpha · November 12, 2026, 19:01 UTC